- Nov 21, 2020
- 1 min
top of page
Rigorous science done transparently
Home: Overview
RESEARCH
The science of psychedelic microdosing
MICRODOSING PSILOCYBIN
Microdosing is more popular than ever, but we still don’t really understand how it works and what it does. There has been a recent groundswell of journalism on the topic, but there is almost no scientific evidence for the effects of this practice. We are preparing a study that will measure the empirical effects of microdosing. Our design will be a double-blind placebo-controlled crossover washout trial. We aim to have 100 participants in our first study.
PUBLICATIONS
We have published some of the first academic research on psychedelic microdosing. Click on the publication link at the top of the page or on the document icon to the left to check them out. You can also scroll down to find media covering our research.
Home: Research
CONSULTING
Helping industry remain scientific and open
Home: Research
OUR TEAM
Home: Team Members
ROTEM PETRANKER
Co-Founder and Director
Rotem Petranker is a psychology PhD Student in David Shore's lab at McMaster University. His main research interests are sustained attention, emotional regulation, and creativity, all of which may be affected by psychedelics. Rotem is passionate about establishing a rigorous framework for the study of psychedelics using the principles of Open Science. His clinical interests include disorders amenable to psychedelic psychotherapy, including mood disorders and OCD.
THOMAS ANDERSON
Co-Founder and Director
Thomas Anderson is a PhD Candidate studying Cognitive Neuroscience at the University of Toronto (Toronto, Canada). Thomas is a strong proponent of Open Science and publicly communicating scientific findings. He has shared our research findings and presentations on ResearchGate to communicate about this research with the public.
MEDIA
CONTACT US
Home: Contact
bottom of page